QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders
This author has yet to write their bio.Meanwhile lets just say that we are proud ysalledechou contributed a whooping 2 entries.
Entries by ysalledechou
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
- RT @MSNewsToday: New Post: BTK Inhibitor SAR442168 Reduces New Lesions in MS Patients, Phase 2 Clinical Trial Results Show https://t.co/O1S…2 days ago
- RT @MS_Bio: Sanofi reported positive results in a study of its new pill to treat multiple sclerosis. httpsbuff.ly39eQL72Â: Sanofi reported…3 days ago
- RT @LEAD_Coalition: White Matter Hyperintensities and #Alzheimers Pathology Associated with Cognitive Impairment Risk https://t.co/ypCi5yeA…6 days ago
- RT @WHO: Today is World #EpilepsyDay. #Epilepsy affects around 50 million people worldwide, making it one of the most common neurological d…6 days ago
130, rue de Lourmel
75015 Paris – France